{"id":24926,"date":"2025-03-28T17:27:47","date_gmt":"2025-03-28T18:27:47","guid":{"rendered":"https:\/\/medexperts.pro\/?p=24926"},"modified":"2025-03-28T18:32:42","modified_gmt":"2025-03-28T18:32:42","slug":"coreweave-disappoints-on-opening-of-trading","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=24926","title":{"rendered":"CoreWeave Disappoints on Opening of Trading"},"content":{"rendered":"
<\/div>\n

The start-up, which provides the processing power to help develop A.I. systems, faces questions about its debt and the overall economy.<\/p>\n

\n
\n
\n

Shares of CoreWeave, the first artificial intelligence start-up to go public, opened their first day of trading on Friday at $39. That was down slightly from the initial public offering price of $40, which CoreWeave set a day earlier after reducing the size and value of its I.P.O.<\/p>\n

The company\u2019s share price, trading under the ticker symbol CRWV, signaled concern among Wall Street investors about the economy and CoreWeave\u2019s business model.<\/p>\n

The fall came amid a slumping stock market<\/a> and uncertainty around inflation and President Trump\u2019s tariffs. And the listing\u2019s reduced price \u2014 CoreWeave estimated a range of $47 to $55 in earlier filings<\/a> \u2014 already reflected skepticism from investors compared with a month ago. The company\u2019s share price increased about 1 percent in early trading.<\/p>\n

CoreWeave, which runs data centers that help power giant A.I. systems, also raised just $1.5 billion in the offering, less than the $4 billion that analysts had anticipated.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

In an interview on Friday, Michael Intrator, CoreWeave\u2019s chief executive, said that concerns about the stock market and the A.I. industry had caused the company to reduce its listing, but the timing of its offering would still benefit the company in the long run.<\/p>\n

\u201cThis is just a day, and we\u2019ll get through this day, and we\u2019ll keep moving,\u201d Mr. Intrator said. \u201cGetting into the public markets is what matters for us.\u201d<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n

We are having trouble retrieving the article content.<\/p>\n

Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into<\/a>\u00a0your Times account, or\u00a0subscribe<\/a>\u00a0for all of The Times.<\/p>\n

\n<\/div>\n
\n
\n

Thank you for your patience while we verify access.<\/p>\n

Already a subscriber?\u00a0Log in<\/a>.<\/p>\n

Want all of The Times?\u00a0Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

The start-up, which provides the processing power to help develop A.I. systems, faces questions about its debt and the overall economy.Shares of CoreWeave, the first artificial intelligence start-up to go public, opened their first day of trading on Friday at $39. That was down slightly from the initial public offering price of $40, which CoreWeave set a day earlier after reducing the size and value of its I.P.O.The company\u2019s share price, trading under the ticker symbol CRWV, signaled concern among Wall Street investors about the economy and CoreWeave\u2019s business model.The fall came amid a slumping stock market and uncertainty around inflation and President Trump\u2019s tariffs. And the listing\u2019s reduced price \u2014 CoreWeave estimated a range of $47 to $55 in earlier filings \u2014 already reflected skepticism from investors compared with a month ago. The company\u2019s share price increased about 1 percent in early trading.CoreWeave, which runs data centers that help power giant A.I. systems, also raised just $1.5 billion in the offering, less than the $4 billion that analysts had anticipated.In an interview on Friday, Michael Intrator, CoreWeave\u2019s chief executive, said that concerns about the stock market and the A.I. industry had caused the company to reduce its listing, but the timing of its offering would still benefit the company in the long run.\u201cThis is just a day, and we\u2019ll get through this day, and we\u2019ll keep moving,\u201d Mr. Intrator said. \u201cGetting into the public markets is what matters for us.\u201dWe are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":24928,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-24926","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/24926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24926"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/24926\/revisions"}],"predecessor-version":[{"id":24929,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/24926\/revisions\/24929"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/24928"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}